Jason Tarkin
Overview
Explore the profile of Jason Tarkin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sriranjan R, Zhao T, Tarkin J, Hubsch A, Helmy J, Vamvaka E, et al.
BMJ Open
. 2022 Oct;
12(10):e062602.
PMID: 36207050
Introduction: Inflammation plays a critical role in the pathogenesis of atherosclerosis, the leading cause of ischaemic heart disease (IHD). Studies in preclinical models have demonstrated that an increase in regulatory...
2.
Bargehr J, Rericha P, Petchey A, Colzani M, Moule G, Malgapo M, et al.
ESC Heart Fail
. 2021 Aug;
8(5):4119-4129.
PMID: 34390216
Aims: Membrane-bound angiotensin-converting enzyme (ACE)2 is the main cellular access point for SARS-CoV-2, but its expression and the effect of ACE inhibition have not been assessed quantitatively in patients with...
3.
Gopalan D, Nordgren-Rogberg A, Le E, Pavey H, Tarkin J, Nyren S, et al.
J Am Heart Assoc
. 2020 Oct;
9(21):e018075.
PMID: 33115320
Background Hypodense filling defects within the pulmonary veins on computed tomography described as pulmonary vein sign (PVS) have been noted in acute pulmonary embolism and shown to be associated with...
4.
Patel K, Tarkin J, Serruys P, Tenekecioglu E, Foin N, Zhang Y, et al.
Expert Rev Cardiovasc Ther
. 2017 Mar;
15(3):165-179.
PMID: 28256179
Advances in our understanding about atherosclerotic evolution have enabled us to identify specific plaque characteristics that are associated with coronary plaque vulnerability and cardiovascular events. With constant improvements in signal...
5.
Tarkin J, Malhotra A, Apps A, Smith R, Di Mario C, Rogers P, et al.
EuroIntervention
. 2014 Apr;
11(5):511-7.
PMID: 24694592
Aims: We aimed to investigate why many patients with ST-segment elevation myocardial infarction (STEMI) initially present to non-primary percutaneous coronary intervention (PPCI) equipped hospitals in a region that offers a...
6.
Echavarria-Pinto M, Gonzalo N, Ibanez B, Petraco R, Jimenez-Quevedo P, Sen S, et al.
Circ Cardiovasc Interv
. 2014 Jan;
7(1):35-42.
PMID: 24399244
Background: Intravenous adenosine infusion produces coronary and systemic vasodilatation, generally leading to systemic hypotension. However, adenosine-induced hypotension during stable hyperemia is heterogeneous, and its relevance to coronary stenoses assessment with...
7.
Apps A, Malhotra A, Tarkin J, Smith R, Kabir T, Lane R, et al.
Postgrad Med J
. 2013 Apr;
89(1053):376-81.
PMID: 23542430
Background: Primary percutaneous coronary intervention (PPCI) programmes vary in admission criteria from open referral to acceptance of electrocardiogram (ECG) protocol positive patients only. Rigid criteria may result in some patients...
8.
Sen S, Escaned J, Malik I, Mikhail G, Foale R, Mila R, et al.
J Am Coll Cardiol
. 2011 Dec;
59(15):1392-402.
PMID: 22154731
Objectives: The purpose of this study was to develop an adenosine-independent, pressure-derived index of coronary stenosis severity. Background: Assessment of stenosis severity with fractional flow reserve (FFR) requires that coronary...
9.
Bhattacharyya S, Tarkin J, Prasad S, De Souza A, Kaddoura S
Eur J Echocardiogr
. 2011 Nov;
12(12):975.
PMID: 22065866
No abstract available.